中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 40 Issue 4
Apr.  2024
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2024  >  40(4): 834-838

Application and development of endoscopic techniques in the diagnosis and treatment of liver diseases

DOI: 10.12449/JCH240431

  • Department of Gastroenterology，The First People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine，Shanghai 200080，China

More Information
  • Corresponding author: LU Lungen， lungenlu1965@163.com （ORCID： 0000-0002-1533-4068）
  • Received Date: 2023-08-16
  • Accepted Date: 2023-09-18
  • Published Date: 2024-04-25
    Abstract
  • Liver disease is one of the most important health problems around the world， and early diagnosis and timely intervention and treatment are the key to preventing liver-related morbidity and mortality rates. The development of endoscopic techniques has provided new diagnostic and intervention methods for liver diseases. This article reviews the application and development of endoscopic techniques in liver diseases from the following aspects： the technical advances and advantages of endoscopic ultrasound-guided liver biopsy； the application and development of endoscopic techniques in the treatment of portal hypertension caused by liver abscess/hepatic cyst and liver diseases， as well as interventional techniques in the treatment of liver tumors； the efficacy and prospects of the endoscopic techniques for weight loss， which are relatively new in China， in the treatment of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Endoscopic techniques may hold promise for wide clinical application and exploration in in liver-related diseases in China， so as to provide more options for patients and doctors.

     

    • FullText(HTML)
  • loading
    • References(50)
  • [1]
    DEVARBHAVI H, ASRANI SK, ARAB JP, et al. Global burden of liver disease: 2023 update[J]. J Hepatol, 2023, 79( 2): 516- 537. DOI: 10.1016/j.jhep.2023.03.017.
    [2]
    TEHAMI NA, SIAU K, BUCHANAN R, et al. Endoscopic ultrasound-guided liver biopsy: Down but not out[J]. Gut, 2022, 71( 3): 654- 655. DOI: 10.1136/gutjnl-2021-324815.
    [3]
    KHURANA S, BUTT W, KHARA HS, et al. Bi-lobar liver biopsy via EUS enhances the assessment of disease severity in patients with non-alcoholic steatohepatitis[J]. Hepatol Int, 2019, 13( 3): 323- 329. DOI: 10.1007/s12072-019-09945-4.
    [4]
    JOHNSON KD, LAOVEERAVAT P, YEE EU, et al. Endoscopic ultrasound guided liver biopsy: Recent evidence[J]. World J Gastrointest Endosc, 2020, 12( 3): 83- 97. DOI: 10.4253/wjge.v12.i3.83.
    [5]
    SCHULMAN AR, THOMPSON CC, ODZE R, et al. Optimizing EUS-guided liver biopsy sampling: Comprehensive assessment of needle types and tissue acquisition techniques[J]. Gastrointest Endosc, 2017, 85( 2): 419- 426. DOI: 10.1016/j.gie.2016.07.065.
    [6]
    HASHIMOTO R, CHANG KJ. Endoscopic ultrasound guided hepatic interventions[J]. Dig Endosc, 2021, 33( 1): 54- 65. DOI: 10.1111/den.13661.
    [7]
    HASAN MK, KADKHODAYAN K, IDRISOV E, et al. Endoscopic ultrasound-guided liver biopsy using a 22-G fine needle biopsy needle: A prospective study[J]. Endoscopy, 2019, 51( 9): 818- 824. DOI: 10.1055/a-0967-3640.
    [8]
    BANG JY, WARD TJ, GUIRGUIS S, et al. Radiology-guided percutaneous approach is superior to EUS for performing liver biopsies[J]. Gut, 2021, 70( 12): 2224- 2226. DOI: 10.1136/gutjnl-2021-324495.
    [9]
    PATEL HK, SAXENA R, RUSH N, et al. A comparative study of 22G versus 19G needles for EUS-guided biopsies for parenchymal liver disease: Are thinner needles better?[J]. Dig Dis Sci, 2021, 66( 1): 238- 246. DOI: 10.1007/s10620-020-06165-x.
    [10]
    DAWOD E, NIETO J, SAAB S. Endoscopic ultrasound-guided liver biopsy: Where do we stand?[J]. Am J Gastroenterol, 2022, 117( 2): 205- 208. DOI: 10.14309/ajg.0000000000001551.
    [11]
    SHAH RM, SCHMIDT J, JOHN E, et al. Superior specimen and diagnostic accuracy with endoscopic ultrasound-guided liver biopsies using 19-gauge versus 22-gauge core needles[J]. Clin Endosc, 2021, 54( 5): 739- 744. DOI: 10.5946/ce.2020.212.
    [12]
    MOHAN BP, MADHU D, REDDY N, et al. Diagnostic accuracy of EUS-guided fine-needle biopsy sampling by macroscopic on-site evaluation: A systematic review and meta-analysis[J]. Gastrointest Endosc, 2022, 96( 6): 909- 917. e 11. DOI: 10.1016/j.gie.2022.07.026.
    [13]
    CHIN YK, ASOKKUMAR R. Endoscopic ultrasound-guided drainage of difficult-to-access liver abscesses[J]. SAGE Open Med, 2020, 8: 2050312120921273. DOI: 10.1177/2050312120921273.
    [14]
    BARON TH, LAPPAS BM. Successful EUS-guided cystoduodenostomy of a large hepatic cyst causing biliary obstruction[J]. Gastrointest Endosc, 2021, 93( 4): 981- 982. DOI: 10.1016/j.gie.2020.12.003.
    [15]
    D\U 02 BCERRICO F, DERHY S, FAZI M, et al. EUS-guided endoscopic internal drainage with lumen-apposing metal stent for symptomatic hepatic cysts: A case series(with video)[J]. Endosc Int Open, 2023, 11( 1): E76- E80. DOI: 10.1055/a-1968-7596.
    [16]
    RANA SS, AHMED S, SHARMA R, et al. Safety and efficacy of EUS-guided drainage of liver abscess: A single-center experience[J]. Endosc Ultrasound, 2020, 9( 5): 350- 351. DOI: 10.4103/eus.eus_41_20.
    [17]
    YAMAMOTO K, ITOI T, TSUCHIYA T, et al. EUS-guided drainage of hepatic abscess in the right side of the liver of a patient with Chilaiditi syndrome[J]. VideoGIE, 2017, 2( 11): 299- 300. DOI: 10.1016/j.vgie.2017.06.013.
    [18]
    CARBAJO AY, BRUNIE VEGAS FJ, GARCÍA-ALONSO FJ, et al. Retrospective cohort study comparing endoscopic ultrasound-guided and percutaneous drainage of upper abdominal abscesses[J]. Dig Endosc, 2019, 31( 4): 431- 438. DOI: 10.1111/den.13342.
    [19]
    VENKATESH V, RANA SS, KUMAR A, et al. Hepatobiliary and Pancreatic: EUS-guided drainage of a ruptured amoebic liver abscess in a child[J]. J Gastroenterol Hepatol, 2020, 35( 6): 921. DOI: 10.1111/jgh.15014.
    [20]
    TAKAHASHI K, OHYAMA H, NAGASHIMA H, et al. Successful endoscopic treatment of huge infected biloma and hepatic abscess after endoscopic ultrasound-guided hepaticogastrostomy with brain abscess[J]. Clin J Gastroenterol, 2022, 15( 5): 988- 993. DOI: 10.1007/s12328-022-01659-9.
    [21]
    de NUCCI G, DELLA CORTE C, REATI R, et al. Endoscopic ultrasound-guided radiofrequency ablation for hepatocellular carcinoma in cirrhosis: A case report test for efficacy and future perspectives[J]. Endosc Int Open, 2020, 8( 11): E1713- E1716. DOI: 10.1055/a-1236-3105.
    [22]
    CARRARA S, ARCIDIACONO PG, ALBARELLO L, et al. Endoscopic ultrasound-guided application of a new internally gas-cooled radiofrequency ablation probe in the liver and spleen of an animal model: A preliminary study[J]. Endoscopy, 2008, 40( 9): 759- 763. DOI: 10.1055/s-2008-1077520.
    [23]
    LI T, KHOKHLOVA T, MALONEY E, et al. Endoscopic high-intensity focused US: Technical aspects and studies in an in vivo porcine model(with video)[J]. Gastrointest Endosc, 2015, 81( 5): 1243- 1250. DOI: 10.1016/j.gie.2014.12.019.
    [24]
    NAKAJI S, HIRATA N, IWAKI K, et al. Endoscopic ultrasound(EUS)-guided ethanol injection for hepatocellular carcinoma difficult to treat with percutaneous local treatment[J]. Endoscopy, 2012, 44(Suppl 2 UCTN): E 380. DOI: 10.1055/s-0032-1309918.
    [25]
    HU YH, TUO XP, JIN ZD, et al. Endoscopic ultrasound(EUS)-guided ethanol injection in hepatic metastatic carcinoma: A case report[J]. Endoscopy, 2010, 42( Suppl 2): E256- E257. DOI: 10.1055/s-0030-1255653.
    [26]
    JIANG TA, DENG Z, TIAN G, et al. Efficacy and safety of endoscopic ultrasonography-guided interventional treatment for refractory malignant left-sided liver tumors: A case series of 26 patients[J]. Sci Rep, 2016, 6: 36098. DOI: 10.1038/srep36098.
    [27]
    LEE EW, SHAHROUKI P, ALANIS L, et al. Management options for gastric variceal hemorrhage[J]. JAMA Surg, 2019, 154( 6): 540- 548. DOI: 10.1001/jamasurg.2019.0407.
    [28]
    LIM YS. Practical approach to endoscopic management for bleeding gastric varices[J]. Korean J Radiol, 2012, 13( Suppl 1): S40- S44. DOI: 10.3348/kjr.2012.13.S1.S40.
    [29]
    LAHOTI S, CATALANO MF, ALCOCER E, et al. Obliteration of esophageal varices using EUS-guided sclerotherapy with color Doppler[J]. Gastrointest Endosc, 2000, 51( 3): 331- 333. DOI: 10.1016/s0016-5107(00)70363-4.
    [30]
    BICK BL, AL-HADDAD M, LIANGPUNSAKUL S, et al. EUS-guided fine needle injection is superior to direct endoscopic injection of 2-octyl cyanoacrylate for the treatment of gastric variceal bleeding[J]. Surg Endosc, 2019, 33( 6): 1837- 1845. DOI: 10.1007/s00464-018-6462-z.
    [31]
    ROBLES-MEDRANDA C, OLEAS R, VALERO M, et al. Endoscopic ultrasonography-guided deployment of embolization coils and cyanoacrylate injection in gastric varices versus coiling alone: A randomized trial[J]. Endoscopy, 2020, 52( 4): 268- 275. DOI: 10.1055/a-1123-9054.
    [32]
    FUJII-LAU LL, LAW R, WONG KEE SONG LM, et al. Endoscopic ultrasound(EUS)-guided coil injection therapy of esophagogastric and ectopic varices[J]. Surg Endosc, 2016, 30( 4): 1396- 1404. DOI: 10.1007/s00464-015-4342-3.
    [33]
    BHAT YM, WEILERT F, FREDRICK RT, et al. EUS-guided treatment of gastric fundal varices with combined injection of coils and cyanoacrylate glue: A large U.S. experience over 6 years(with video)[J]. Gastrointest Endosc, 2016, 83( 6): 1164- 1172. DOI: 10.1016/j.gie.2015.09.040.
    [34]
    RYOU M, DEWITT JM, DAS KK, et al. AGA clinical practice update on interventional EUS for vascular investigation and therapy: Commentary[J]. Clin Gastroenterol Hepatol, 2023, 21( 7): 1699- 1705.e2. DOI: 10.1016/j.cgh.2023.03.027.
    [35]
    ZHANG W, PENG CY, ZHANG S, et al. EUS-guided portal pressure gradient measurement in patients with acute or subacute portal hypertension[J]. Gastrointest Endosc, 2021, 93( 3): 565- 572. DOI: 10.1016/j.gie.2020.06.065.
    [36]
    CHOI AY, KOLB J, SHAH S, et al. Endoscopic ultrasound-guided portal pressure gradient with liver biopsy: 6 years of endo-hepatology in practice[J]. J Gastroenterol Hepatol, 2022, 37( 7): 1373- 1379. DOI: 10.1111/jgh.15875.
    [37]
    ESTES C, RAZAVI H, LOOMBA R, et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease[J]. Hepatology, 2018, 67( 1): 123- 133. DOI: 10.1002/hep.29466.
    [38]
    CHALASANI N, YOUNOSSI Z, LAVINE JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology[J]. Gastroenterology, 2012, 142( 7): 1592- 1609. DOI: 10.1053/j.gastro.2012.04.001.
    [39]
    DAYYEH BK ABU, BAZERBACHI F, GRAUPERA I, et al. Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease[J]. J Hepatol, 2019, 71( 6): 1246- 1248. DOI: 10.1016/j.jhep.2019.07.026.
    [40]
    SALOMONE F, CURRENTI W, MAGRÌ G, et al. Effects of intragastric balloon in patients with nonalcoholic fatty liver disease and advanced fibrosis[J]. Liver Int, 2021, 41( 9): 2112- 2116. DOI: 10.1111/liv.14917.
    [41]
    LEE YM, LOW HC, LIM LG, et al. Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: A pilot study[J]. Gastrointest Endosc, 2012, 76( 4): 756- 760. DOI: 10.1016/j.gie.2012.05.023.
    [42]
    BAZERBACHI F, VARGAS EJ, RIZK M, et al. Intragastric balloon placement induces significant metabolic and histologic improvement in patients with nonalcoholic steatohepatitis[J]. Clin Gastroenterol Hepatol, 2021, 19( 1): 146- 154. e 4. DOI: 10.1016/j.cgh.2020.04.068.
    [43]
    HAJIFATHALIAN K, MEHTA A, ANG B, et al. Improvement in insulin resistance and estimated hepatic steatosis and fibrosis after endoscopic sleeve gastroplasty[J]. Gastrointest Endosc, 2021, 93( 5): 1110- 1118. DOI: 10.1016/j.gie.2020.08.023.
    [44]
    JIRAPINYO P, ZUCKER SD, THOMPSON CC. Regression of hepatic fibrosis after endoscopic gastric plication in nonalcoholic fatty liver disease[J]. Am J Gastroenterol, 2023, 118( 6): 983- 990. DOI: 10.14309/ajg.0000000000002087.
    [45]
    RUBAN A, GLAYSHER MA, MIRAS AD, et al. A duodenal sleeve bypass device added to intensive medical therapy for obesity with type 2 diabetes: a RCT[M/OL]. Southampton(UK): NIHR Journals Library, 2020.[ 2023-08-07]. http://www.ncbi.nlm.nih.gov/books/NBK564056/. http://www.ncbi.nlm.nih.gov/books/NBK564056/
    [46]
    KARLAS T, PETROFF D, FEISTHAMMEL J, et al. Endoscopic bariatric treatment with duodenal-jejunal bypass liner improves non-invasive markers of non-alcoholic steatohepatitis[J]. Obes Surg, 2022, 32( 8): 2495- 2503. DOI: 10.1007/s11695-022-06150-5.
    [47]
    de JONGE C, RENSEN SS, KOEK GH, et al. Endoscopic duodenal-jejunal bypass liner rapidly improves plasma parameters of nonalcoholic fatty liver disease[J]. Clin Gastroenterol Hepatol, 2013, 11( 11): 1517- 1520. DOI: 10.1016/j.cgh.2013.07.029.
    [48]
    REN MT, ZHOU XX, YU MS, et al. Prospective study of a new endoscopic duodenal-jejunal bypass sleeve in obese patients with nonalcoholic fatty liver disease(with video)[J]. Dig Endosc, 2023, 35( 1): 58- 66. DOI: 10.1111/den.14409.
    [49]
    MINGRONE G, van BAAR AC, DEVIÈRE J, et al. Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: The randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial[J]. Gut, 2022, 71( 2): 254- 264. DOI: 10.1136/gutjnl-2020-323608.
    [50]
    van BAAR ACG, BEUERS U, WONG K, et al. Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results[J]. JHEP Rep, 2019, 1( 6): 429- 437. DOI: 10.1016/j.jhepr.2019.10.006.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (314) PDF downloads(43) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return